+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Balloon Catheters Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • June 2024
  • Region: Asia Pacific
  • Expert Market Research
  • ID: 5984356
The global balloon catheters market size was valued at USD 4.5 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the rising prevalence of cardiovascular diseases. It is expected to grow at a CAGR of 13.20% during the forecast period of 2024-2032, with the values likely to attain USD 8.1 billion by 2032.

Key Takeaways

  • In Asia Pacific, the prevalence of cardiovascular diseases is rising, with studies reporting that South Asians have the highest coronary artery disease (CAD) rate at 24%. The increasing disease burden directly impacts the market demand.
  • The rising availability of advanced catheter-based systems is poised to influence the Asia Pacific balloon catheters market share. In April 2024, TekniPlex Healthcare showcased its recently added catheter design and manufacturing capabilities at the China International Medical Equipment Fair (CMEF) in Shanghai.
  • One of the major market trends is the influx of growth capital to support the advancement of balloon catheter products. In April 2023, Innvolution Group secured funds from an investment firm, OrbiMed, to boost its research and development activities and enable market expansion of its interventional cardiology portfolio including balloon catheters.

Asia Pacific Balloon Catheters Market Analysis

Balloon catheters are specialized medical devices with a long, flexible tube with an inflatable balloon at its tip. Its application is primarily involved in angioplasty procedures, where it is used to open blocked or narrowed blood vessels and improve blood flow. Balloon catheters play a crucial role in minimally invasive procedures, leading to reduced recovery times and lower risk as compared to open surgeries. The rising patient inclination towards less invasive surgical techniques and the increasing use of the device in interventional cardiology is expected to drive the Asia Pacific balloon catheters market growth.

In Asia Pacific, the prevalence of cardiovascular diseases is rising, with studies reporting that South Asians have the highest coronary artery disease (CAD) rate at 24%. This increase is attributed to factors such as the growing elderly population and lifestyle changes. The high prevalence rate directly impacts the market demand as balloon catheters are widely used in treatments like angioplasty and stent placements. Moreover, the surge in the demand for these medical devices is also stimulating technological innovations and attracting substantial investments from key market players which is likely to fuel Asia Pacific balloon catheters market share.

In April 2024, TekniPlex Healthcare, a leading provider of medical device components and material science solutions, showcased its recently added catheter design and manufacturing capabilities at the China International Medical Equipment Fair (CMEF) in Shanghai. The company highlighted its PTA/PTCA Balloon Catheter Tubing for applications in coronary and non-coronary angioplasty applications. The product is manufactured and extruded in ISO-certified cleanrooms as well as holds the ability to incorporate up to three layers of specified raw materials. The rising availability of such product service solutions for catheter-based systems is anticipated to elevate the Asia Pacific balloon catheters market value in the forecast period.

One of the major market trends is surge in growth capital to support the advancement of balloon catheter products. In April 2023, India-based Innvolution Group secured funds from a global healthcare-focused investment firm, OrbiMed, to boost its research and development activities and accelerate market expansion. The company comprises two merged entities, Innvolution Healthcare Private Limited (IHPL) and Innovation Imaging Technologies Private Limited (IITPL), boasting a comprehensive portfolio in interventional cardiology including balloon catheters and drug-eluting stents. Such investment initiatives are expected to propel the market growth and support the development of innovative balloon catheter devices that deliver enhanced clinical outcomes.

Asia Pacific Balloon Catheters Market Segmentation

Market Breakup by Product Type

  • PTA Balloon Catheters
  • PTCA Balloon Catheters
  • Occlusion Balloon Catheters
  • Foley Catheters
  • Nephrostomy Balloon Catheters
  • Drug-Eluting Catheters
  • Normal Balloon Catheter
  • Cutting Balloon Catheter
  • Scoring Balloon Catheter
  • Drug Eluting Balloon Catheter
  • Stent Graft Balloon Catheter
  • Others

Market Breakup by Catheter Type

  • Fixed Wire
  • Over-The-Wire
  • Rapid Exchange

Market Breakup by Balloon Type

  • Non-Compliant
  • Semi-Compliant
  • Compliant

Market Breakup by Material

  • Polyurethane
  • Nylon
  • Others

Market Breakup by Indication

  • Coronary Artery Disease
  • Peripheral Vascular Disease

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Others

Market Breakup by Countries

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Asia Pacific Balloon Catheters Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Stryker
  • B.Braun Melsungen AG
  • Johnson & Johnson
  • Teleflex Incorporated
  • Medtronic, Plc.
  • Edwards Lifesciences Corporation
  • BIOTRONIK
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

What is the Asia Pacific balloon catheters market forecast outlook for 2024-2032?
The Asia Pacific balloon catheters market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 and is likely to reach a market value of USD 8.1 billion by 2032.

What are the major factors aiding the Asia Pacific balloon catheters market demand?
The growing prevalence rate of cardiovascular diseases and the rising patient inclination towards less invasive surgical techniques is fuelling the demand for the market.

What are the major Asia Pacific balloon catheters market trends?
One of the significant trends in the market is the increased influx of growth capital to support the advancement of balloon catheter products. In April 2023, Innvolution Group secured funds from an investment firm, OrbiMed, to boost its research and development activities and enable market expansion of its interventional cardiology portfolio including balloon catheters.

What is the market segmentation based on the product type?
Based on the product type, the market is segmented into PTA Balloon Catheters, PTCA Balloon Catheters, Occlusion Balloon Catheters, Foley Catheters, Nephrostomy Balloon Catheters, Drug-Eluting Catheters, Normal Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Drug Eluting Balloon Catheter, and Stent Graft Balloon Catheter, among others.

What is the market segmentation based on the catheter type?
Based on the catheter type, the market is segmented into fixed wire, over-the-wire, and rapid exchange catheter.

What is the market breakup by balloon type?
Based on the balloon type, the market includes non-compliant, semi-compliant, and compliant catheters.

What is the market breakup by material?
Based on the material, the market includes polyurethane, and nylon, among others.

What is the market breakup by indication?
Based on indication, the market includes coronary artery disease and peripheral vascular disease.

What are the major end users of balloon catheters?
Major end users include hospitals and specialty clinics, among others.

What is the market segmentation by countries?
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.

Who are the key players involved in the Asia Pacific balloon catheters market?
The key players in the market are Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Stryker, B.Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic, Plc., Edwards Lifesciences Corporation, and BIOTRONIK.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asia Pacific Balloon Catheters Market Overview
3.1 Asia Pacific Balloon Catheters Market Historical Value (2017-2023)
3.2 Asia Pacific Balloon Catheters Market Forecast Value (2024-2032)
4 Asia Pacific Balloon Catheters Market Landscape*
4.1 Asia Pacific Balloon Catheters: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Asia Pacific Balloon Catheters: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Catheters Type
4.2.3 Analysis by Balloon Type
5 Asia Pacific Balloon Catheters Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Asia Pacific Balloon Catheters Market Segmentation (2017-2032)
6.1 Asia Pacific Balloon Catheters Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 PTA Balloon Catheters
6.1.3 PTCA Balloon Catheters
6.1.4 Occlusion Balloon Catheters
6.1.5 Foley Catheters
6.1.6 Nephrostomy Balloon Catheters
6.1.7 Drug -Eluting Catheters
6.1.8 Normal Balloon Catheter
6.1.9 Cutting Balloon Catheter
6.1.10 Scoring Balloon Catheter
6.1.11 Drug Eluting Balloon Catheter
6.1.12 Stent Graft Balloon Catheter
6.1.13 Others
6.2 Asia Pacific Balloon Catheters Market (2017-2032) by Catheter Type
6.2.1 Market Overview
6.2.2 Fixed Wire
6.2.3 Over -The -Wire
6.2.4 Rapid Exchange
6.3 Asia Pacific Balloon Catheters Market (2017-2032) by Balloon Type
6.3.1 Market Overview
6.3.2 Non-Compliant
6.3.3 Semi-Compliant
6.3.4 Compliant
6.4 Asia Pacific Balloon Catheters Market (2017-2032) by Material
6.4.1 Market Overview
6.4.2 Polyurethane
6.4.3 Nylon
6.4.4 Others
6.5 Asia Pacific Balloon Catheters Market (2017-2032) by Indication
6.5.1 Market Overview
6.5.2 Coronary Artery Disease
6.5.3 Peripheral Vascular Disease
6.6 Asia Pacific Balloon Catheters Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Specialty Clinics
6.6.4 Others
6.7 Asia Pacific Balloon Catheters Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 China
6.7.3 Japan
6.7.4 ASEAN
6.7.5 Australia
6.7.6 India
6.7.7 Others
7 China Balloon Catheters Market (2017-2032)
7.1 China Balloon Catheters Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 PTA Balloon Catheters
7.1.3 PTCA Balloon Catheters
7.1.4 Occlusion Balloon Catheters
7.1.5 Foley Catheters
7.1.6 Nephrostomy Balloon Catheters
7.1.7 Drug -Eluting Catheters
7.1.8 Normal Balloon Catheter
7.1.9 Cutting Balloon Catheter
7.1.10 Scoring Balloon Catheter
7.1.11 Drug Eluting Balloon Catheter
7.1.12 Stent Graft Balloon Catheter
7.1.13 Others
7.2 China Balloon Catheters Market (2017-2032) by Catheter Type
7.2.1 Market Overview
7.2.2 Fixed Wire
7.2.3 Over -The -Wire
7.2.4 Rapid Exchange
7.3 China Balloon Catheters Market (2017-2032) by Balloon Type
7.3.1 Market Overview
7.3.2 Non-Compliant
7.3.3 Semi-Compliant
7.3.4 Compliant
7.4 China Balloon Catheters Market (2017-2032) by Material
7.4.1 Market Overview
7.4.2 Polyurethane
7.4.3 Nylon
7.4.4 Others
7.5 China Balloon Catheters Market (2017-2032) by Indication
7.5.1 Market Overview
7.5.2 Coronary Artery Disease
7.5.3 Peripheral Vascular Disease
7.6 China Balloon Catheters Market (2017-2032) by End User
7.6.1 Market Overview
7.6.2 Hospitals
7.6.3 Specialty Clinics
7.6.4 Others
8 Japan Ballon Catheters Market (2017-2032)
8.1 Japan Balloon Catheters Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 PTA Balloon Catheters
8.1.3 PTCA Balloon Catheters
8.1.4 Occlusion Balloon Catheters
8.1.5 Foley Catheters
8.1.6 Nephrostomy Balloon Catheters
8.1.7 Drug -Eluting Catheters
8.1.8 Normal Balloon Catheter
8.1.9 Cutting Balloon Catheter
8.1.10 Scoring Balloon Catheter
8.1.11 Drug Eluting Balloon Catheter
8.1.12 Stent Graft Balloon Catheter
8.1.13 Others
8.2 Japan Balloon Catheters Market (2017-2032) by Catheter Type
8.2.1 Market Overview
8.2.2 Fixed Wire
8.2.3 Over -The -Wire
8.2.4 Rapid Exchange
8.3 Japan Balloon Catheters Market (2017-2032) by Balloon Type
8.3.1 Market Overview
8.3.2 Non-Compliant
8.3.3 Semi-Compliant
8.3.4 Compliant
8.4 Japan Balloon Catheters Market (2017-2032) by Material
8.4.1 Market Overview
8.4.2 Polyurethane
8.4.3 Nylon
8.4.4 Others
8.5 Japan Balloon Catheters Market (2017-2032) by Indication
8.5.1 Market Overview
8.5.2 Coronary Artery Disease
8.5.3 Peripheral Vascular Disease
8.6 Japan Balloon Catheters Market (2017-2032) by End User
8.6.1 Market Overview
8.6.2 Hospitals
8.6.3 Specialty Clinics
8.6.4 Others
9 ASEAN Ballon Catheters Market (2017-2032)
9.1 ASEAN Balloon Catheters Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 PTA Balloon Catheters
9.1.3 PTCA Balloon Catheters
9.1.4 Occlusion Balloon Catheters
9.1.5 Foley Catheters
9.1.6 Nephrostomy Balloon Catheters
9.1.7 Drug -Eluting Catheters
9.1.8 Normal Balloon Catheter
9.1.9 Cutting Balloon Catheter
9.1.10 Scoring Balloon Catheter
9.1.11 Drug Eluting Balloon Catheter
9.1.12 Stent Graft Balloon Catheter
9.1.13 Others
9.2 ASEAN Balloon Catheters Market (2017-2032) by Catheter Type
9.2.1 Market Overview
9.2.2 Fixed Wire
9.2.3 Over -The -Wire
9.2.4 Rapid Exchange
9.3 ASEAN Balloon Catheters Market (2017-2032) by Balloon Type
9.3.1 Market Overview
9.3.2 Non-Compliant
9.3.3 Semi-Compliant
9.3.4 Compliant
9.4 ASEAN Balloon Catheters Market (2017-2032) by Material
9.4.1 Market Overview
9.4.2 Polyurethane
9.4.3 Nylon
9.4.4 Others
9.5 ASEAN Balloon Catheters Market (2017-2032) by Indication
9.5.1 Market Overview
9.5.2 Coronary Artery Disease
9.5.3 Peripheral Vascular Disease
9.6 ASEAN Balloon Catheters Market (2017-2032) by End User
9.6.1 Market Overview
9.6.2 Hospitals
9.6.3 Specialty Clinics
9.6.4 Others
10 Australia Ballon Catheters Market (2017-2032)
10.1 Australia Balloon Catheters Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 PTA Balloon Catheters
10.1.3 PTCA Balloon Catheters
10.1.4 Occlusion Balloon Catheters
10.1.5 Foley Catheters
10.1.6 Nephrostomy Balloon Catheters
10.1.7 Drug -Eluting Catheters
10.1.8 Normal Balloon Catheter
10.1.9 Cutting Balloon Catheter
10.1.10 Scoring Balloon Catheter
10.1.11 Drug Eluting Balloon Catheter
10.1.12 Stent Graft Balloon Catheter
10.1.13 Others
10.2 Australia Balloon Catheters Market (2017-2032) by Catheter Type
10.2.1 Market Overview
10.2.2 Fixed Wire
10.2.3 Over -The -Wire
10.2.4 Rapid Exchange
10.3 Australia Balloon Catheters Market (2017-2032) by Balloon Type
10.3.1 Market Overview
10.3.2 Non-Compliant
10.3.3 Semi-Compliant
10.3.4 Compliant
10.4 Australia Balloon Catheters Market (2017-2032) by Material
10.4.1 Market Overview
10.4.2 Polyurethane
10.4.3 Nylon
10.4.4 Others
10.5 Australia Balloon Catheters Market (2017-2032) by Indication
10.5.1 Market Overview
10.5.2 Coronary Artery Disease
10.5.3 Peripheral Vascular Disease
10.6 Australia Balloon Catheters Market (2017-2032) by End User
10.6.1 Market Overview
10.6.2 Hospitals
10.6.3 Specialty Clinics
10.6.4 Others
11 India Ballon Catheters Market (2017-2032)
11.1 India Balloon Catheters Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 PTA Balloon Catheters
11.1.3 PTCA Balloon Catheters
11.1.4 Occlusion Balloon Catheters
11.1.5 Foley Catheters
11.1.6 Nephrostomy Balloon Catheters
11.1.7 Drug -Eluting Catheters
11.1.8 Normal Balloon Catheter
11.1.9 Cutting Balloon Catheter
11.1.10 Scoring Balloon Catheter
11.1.11 Drug Eluting Balloon Catheter
11.1.12 Stent Graft Balloon Catheter
11.1.13 Others
11.2 India Balloon Catheters Market (2017-2032) by Catheter Type
11.2.1 Market Overview
11.2.2 Fixed Wire
11.2.3 Over -The -Wire
11.2.4 Rapid Exchange
11.3 India Balloon Catheters Market (2017-2032) by Balloon Type
11.3.1 Market Overview
11.3.2 Non-Compliant
11.3.3 Semi-Compliant
11.3.4 Compliant
11.4 India Balloon Catheters Market (2017-2032) by Material
11.4.1 Market Overview
11.4.2 Polyurethane
11.4.3 Nylon
11.4.4 Others
11.5 India Balloon Catheters Market (2017-2032) by Indication
11.5.1 Market Overview
11.5.2 Coronary Artery Disease
11.5.3 Peripheral Vascular Disease
11.6 India Balloon Catheters Market (2017-2032) by End User
11.6.1 Market Overview
11.6.2 Hospitals
11.6.3 Specialty Clinics
11.6.4 Others
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share by Top 5 Companies
16.2 Abbott Laboratories
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Becton Dickinson and Company
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Boston Scientific Corporation
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Stryker
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 B.Braun Melsungen AG
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Johnson & Johnson
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Teleflex Incorporated
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Medtronic, Plc.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Edwards Lifesciences Corporation
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 BIOTRONIK.
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Asia Pacific Balloon Catheters Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The team strives to make this section as comprehensive as possible.

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Stryker
  • B.Braun Melsungen AG
  • Johnson & Johnson
  • Teleflex Incorporated
  • Medtronic Plc.
  • Edwards Lifesciences Corporation
  • BIOTRONIK.

Methodology

Loading
LOADING...